Business Description
Paradigm Biopharmaceuticals Ltd
ISIN : AU000000PAR5
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 115.69 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.01 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.06 | |||||
Beneish M-Score | -4.63 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -45.6 | |||||
3-Year EPS without NRI Growth Rate | -44.8 | |||||
3-Year FCF Growth Rate | -47.1 | |||||
3-Year Book Growth Rate | -26.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.99 | |||||
9-Day RSI | 40.85 | |||||
14-Day RSI | 41.52 | |||||
6-1 Month Momentum % | -30.77 | |||||
12-1 Month Momentum % | -67.72 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.83 | |||||
Quick Ratio | 3.83 | |||||
Cash Ratio | 3.07 | |||||
Days Sales Outstanding | 37117.02 | |||||
Days Payable | 396135.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.6 | |||||
Shareholder Yield % | -31.53 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.81 | |||||
Operating Margin % | -183850 | |||||
Net Margin % | -164288.1 | |||||
FCF Margin % | -186797.62 | |||||
ROE % | -128.46 | |||||
ROA % | -103.18 | |||||
ROIC % | -1859.61 | |||||
ROC (Joel Greenblatt) % | -20450.69 | |||||
ROCE % | -127.6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.66 | |||||
Price-to-Tangible-Book | 2.78 | |||||
EV-to-EBIT | -0.78 | |||||
EV-to-EBITDA | -0.78 | |||||
EV-to-Revenue | 1293.59 | |||||
EV-to-FCF | -0.71 | |||||
Price-to-Net-Current-Asset-Value | 2.78 | |||||
Price-to-Net-Cash | 4.17 | |||||
Earnings Yield (Greenblatt) % | -127.44 | |||||
FCF Yield % | -89.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Paradigm Biopharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 0.042 | ||
EPS (TTM) (A$) | -0.232 | ||
Beta | 0.8 | ||
Volatility % | 58.97 | ||
14-Day RSI | 41.52 | ||
14-Day ATR (A$) | 0.017493 | ||
20-Day SMA (A$) | 0.2605 | ||
12-1 Month Momentum % | -67.72 | ||
52-Week Range (A$) | 0.23 - 1.065055 | ||
Shares Outstanding (Mil) | 350.36 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Paradigm Biopharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Paradigm Biopharmaceuticals Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Paradigm Biopharmaceuticals Ltd Frequently Asked Questions
What is Paradigm Biopharmaceuticals Ltd(ASX:PAR)'s stock price today?
When is next earnings date of Paradigm Biopharmaceuticals Ltd(ASX:PAR)?
Does Paradigm Biopharmaceuticals Ltd(ASX:PAR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |